New tools for the construction of replication-competent adenoviral vectors with altered E1A regulation

被引:12
作者
Avvakumov, N
Mymryk, JS
机构
[1] Univ Western Ontario, Dept Microbiol & Immunol, London Regional Canc Ctr, London, ON N6A 4L6, Canada
[2] Univ Western Ontario, London Regional Canc Ctr, Dept Pharmacol & Toxicol, London, ON N6A 4L6, Canada
[3] Univ Western Ontario, London Regional Canc Ctr, Dept Oncol, London, ON N6A 4L6, Canada
关键词
adenoviral vectors; conditionally-replicating adenovirus; E1A regulation;
D O I
10.1016/S0166-0934(01)00440-2
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
We ha,e designed new vectors for the construction of recombinant adenoviruses containing the early region 1A (E1A) gene under the transcriptional control of heterologous promoters. The normal E1A regulatory elements have been replaced by a convenient set of unique restriction enzyme sites, allowing for introduction of gene regulatory cassettes with relative case. Subsequent rescue generates recombinant conditionally replicating adenovirus in which the transcription of E1A is under alternative control. This allows potentially cell-type specific expression of E1A, restricting efficient virus replication to chosen target cells. It is shown that in several viruses rescued using these constructs. E1A expression is regulated by the heterologous promoters in the expected manner. Specifically, a virus with E1A under the control of the human Cytomegalovirus Immediate Early promoter produced constitutively high levels of E1A. A second virus, with E1A expression regulated by the glucocorticoid-responsive Mouse Mammary Tumor Virus promoter produced E1A expression in a dose-dependent manner upon dexamethasone treatment. Efficient growth of this second virus also required the presence of dexamethasone. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 33 条
[1]
Replicative adenoviruses for cancer therapy [J].
Alemany, R ;
Balagué, C ;
Curiel, DT .
NATURE BIOTECHNOLOGY, 2000, 18 (07) :723-727
[2]
BAYLEY ST, 1994, INT J ONCOL, V5, P425
[3]
AN EFFICIENT AND FLEXIBLE SYSTEM FOR CONSTRUCTION OF ADENOVIRUS VECTORS WITH INSERTIONS OR DELETIONS IN EARLY REGION-1 AND REGION-3 [J].
BETT, AJ ;
HADDARA, W ;
PREVEC, L ;
GRAHAM, FL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8802-8806
[4]
TRANSFORMATION BY HUMAN ADENOVIRUSES [J].
BRANTON, PE ;
BAYLEY, ST ;
GRAHAM, FL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 780 (01) :67-94
[5]
COOPERATIVE BINDING OF EF-1A TO THE E1A ENHANCER REGION MEDIATES SYNERGISTIC EFFECTS ON E1A TRANSCRIPTION DURING ADENOVIRUS INFECTION [J].
BRUDER, JT ;
HEARING, P .
JOURNAL OF VIROLOGY, 1991, 65 (09) :5084-5087
[6]
MULTIFUNCTIONAL YEAST HIGH-COPY-NUMBER SHUTTLE VECTORS [J].
CHRISTIANSON, TW ;
SIKORSKI, RS ;
DANTE, M ;
SHERO, JH ;
HIETER, P .
GENE, 1992, 110 (01) :119-122
[7]
Curiel DT, 2000, CLIN CANCER RES, V6, P3395
[8]
EAGLE H, 1955, P SOC EXP BIOL MED, V89, P362
[9]
CHARACTERISTICS OF A HUMAN CELL LINE TRANSFORMED BY DNA FROM HUMAN ADENOVIRUS TYPE-5 [J].
GRAHAM, FL ;
SMILEY, J ;
RUSSELL, WC ;
NAIRN, R .
JOURNAL OF GENERAL VIROLOGY, 1977, 36 (JUL) :59-72
[10]
A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma [J].
Hallenbeck, PL ;
Chang, YN ;
Hay, C ;
Golightly, D ;
Stewart, D ;
Lin, J ;
Phipps, S ;
Chiang, YL .
HUMAN GENE THERAPY, 1999, 10 (10) :1721-1733